Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Associated Orbitopathy”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Large-scale testing (Phase 3)Study completedNCT06384547
What this trial is testing

A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 231
Not applicableStudy completedNCT07393230
What this trial is testing

Changes in Orbital Macrovascular and Intraocular Microvascular Blood Flow After Orbital Decompression Surgery in Patients With Thyroid Eye Disease

Who this might be right for
Thyroid Associated Orbitopathy
Marmara University Pendik Training and Research Hospital 15
Testing effectiveness (Phase 2)Study completedNCT01727973
What this trial is testing

Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy

Who this might be right for
Graves OphthalmopathyGraves DiseaseEye Diseases+6 more
Sun Yat-sen University 14
Not applicableStudy completedNCT07341347
What this trial is testing

OCT Angiography Drived Alterations in Thyroid-associated Orbitopathy

Who this might be right for
Thyroid Associated Orbitopathy
Osijek University Hospital 68
Large-scale testing (Phase 3)Study completedNCT05176639
What this trial is testing

A Safety, Tolerability and Efficacy Study of Veligrotug (VRDN 001) in Healthy Volunteers and Participants With Thyroid Eye Disease (TED) ( THRIVE )

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 113
Large-scale testing (Phase 3)Study completedNCT03298867
What this trial is testing

Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study

Who this might be right for
Thyroid Eye DiseaseGraves' Orbitopathy
Amgen 83
Testing effectiveness (Phase 2)Study completedNCT01868997
What this trial is testing

Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease

Who this might be right for
Thyroid Associated OphthalmopathiesThyroid-Associated Ophthalmopathy
Amgen 88
Large-scale testing (Phase 3)Study completedNCT01297699
What this trial is testing

Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)

Who this might be right for
Thyroid Associated OphthalmopathiesGraves´ OphthalmopathyThyroid Eye Disease
Hospital Clinico Universitario de Santiago 32
Early research (Phase 1)Study completedNCT06563856
What this trial is testing

TEPEZZA Subcutaneous Administration in Healthy Adults

Who this might be right for
BioavailabilityBioequivalence
Amgen 37
Large-scale testing (Phase 3)Active Not RecruitingNCT06625398
What this trial is testing

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 204
Early research (Phase 1)Study completedNCT06674941
What this trial is testing

A Trial to Investigate Teprotumumab (High-concentration Formulation) Subcutaneous Administration in Healthy Adult Non-Japanese and Japanese Participants

Who this might be right for
Healthy Volunteers
Amgen 44
Post-approval studies (Phase 4)Not Yet RecruitingNCT03098225
What this trial is testing

A Trial to Evaluate the Efficacy of Orbital Radiotherapy in Graves' Orbitopathy

Who this might be right for
Thyroid Associated Ophthalmopathy
University of Pisa 120
Large-scale testing (Phase 3)Looking for participantsNCT06112340
What this trial is testing

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves OrbitopathyEndocrine System Diseases+9 more
Sling Therapeutics, Inc. 75
Large-scale testing (Phase 3)UnknownNCT01809444
What this trial is testing

Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy

Who this might be right for
Thyroid Associated Opthalmopathies
Sun Yat-sen University 146
Not applicableApproved For MarketingNCT04040894
What this trial is testing

Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease

Who this might be right for
Thyroid Eye DiseaseGraves' Orbitopathy
Amgen
Not applicableNot Yet RecruitingNCT07623993
What this trial is testing

Prospective Observational Study of Smartphone-Based AI Self-Monitoring During Non-Surgical Treatment for Thyroid Eye Disease (THYROSCOPE)

Who this might be right for
Thyroid Eye Disease (TED)Graves OphthalmopathyThyroid Associated Ophthalmopathies
THYROSCOPE INC. 200
Not applicableStudy completedNCT05731154
What this trial is testing

Development of an AI Solution to Evaluate Clinical Activity of TAO Using Periocular Images Taken by Smartphones in Patients With Thyroid Dysfunction

Who this might be right for
Thyroid Eye Disease
Seoul National University Bundang Hospital 100
Large-scale testing (Phase 3)Study completedNCT06021054
What this trial is testing

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 188
Testing effectiveness (Phase 2)Study completedNCT03110848
What this trial is testing

Effects of Atorvastatin in Graves' Orbitopathy (GO)

Who this might be right for
Thyroid Associated OphthalmopathyHypercholesterolemia
University of Pisa 88
Large-scale testing (Phase 3)WithdrawnNCT02112643
What this trial is testing

Selenium in Mild Thyroid Eye Disease in North America

Who this might be right for
Thyroid Associated Ophthalmopathies
Columbia University
Load More Results